Pfizer (PFIZER)
FAST GROWERFairStock Score: 60/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹4,783.2 |
| Market Cap | ₹23,158.42 Cr |
| P/E Ratio | 30.41 |
| ROCE | 21.62% |
| ROE | 20.24% |
| Dividend Yield | 0.69% |
| Profit Growth | -6.94% |
| Debt/Equity | 0 |
| Sales Growth | 9.3% |
| Free Cash Flow | ₹15,900 Cr |
| Promoter Holding | 63.92% |
| 52-Week Range | ₹4,396.7 — ₹5,993 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹921.88 |
Pfizer trades with a P/E ratio of 30.41, ROCE of 21.62%, ROE of 20.24%, profit growth of -6.94%, debt-to-equity of 0. The FairStock Score of 60/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer